Innoviva (INVA)

• Market cap: $1.15B
• 1 day: 1.39%
• 5 days: 2.13%
• 1 month: -0.27%
• 3 months: 0.17%
• 6 months: -2.62%
• Year to date: 4.6%
• 1 year: -6.95%
• 5 years: 77.56%
• 10 years: 104.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Employees: 127